Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Stock Traders Daily
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Akorn Inc divests ECR Pharmaceuticals to Valeant

Friday, 20 Jun 2014 11:11am EDT 

Akorn Inc:Says it sold its subsidiary, ECR Pharmaceuticals (ECR), to Valeant Pharmaceuticals for $41 mln in cash and assumption of certain liabilities.ECR, which promotes certain branded pharmaceuticals through its sales force, was acquired through the acquisition of Hi-Tech Pharmacal. 

Company Quote

2.69 +1.89%
21 Nov 2014